Inherited and acquired genetic factors involved in the development of CLL
John Gribben et al.
Highlights from the International Workshop of the German CLL Study Group
Combining CLL drugs to overcome the problem of resistance
The importance of detecting MRD in the treatment of AML
Understanding the mechanisms of venetoclax and ibrutinib resistance